CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing laboratory. We offer the CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test for individuals who may be at risk of this genetic disorder. Our comprehensive test provides accurate results and valuable information for diagnosis and treatment options.
Test Details
The CACNA1A gene is associated with a condition called spinocerebellar ataxia type 6 (SCA6). SCA6 is an autosomal dominant genetic disorder that affects the cerebellum, which is the part of the brain responsible for coordinating movement.
Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, providing a comprehensive analysis of the CACNA1A gene. This advanced testing method can identify mutations or variations in the gene that are associated with SCA6.
By analyzing the CACNA1A gene, our NGS testing can determine if a person has a mutation or variation that is known to cause SCA6. This information is crucial for accurate diagnosis, genetic counseling, and treatment planning.
It’s important to note that our NGS genetic testing can also identify other genetic variations that may not be directly related to SCA6 but could have implications for an individual’s health. Therefore, it’s essential to consult with a healthcare professional or genetic counselor to interpret the results accurately and understand their implications.
Test Components and Price
Our CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test is priced at AED 4400.0.
Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre-Test Information
Before undergoing the CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with this genetic disorder. This information is crucial for accurate interpretation of the test results.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test can provide valuable insights into your genetic health. Contact us today to schedule your test and take control of your genetic well-being.
Test Name | CACNA1A Gene Spinocerebellar ataxia type 6 autosomal dominant Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CACNA1A Gene Spinocerebellar ataxia type 6, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1A Gene Spinocerebellar ataxia type 6, autosomal dominant |
Test Details |
The CACNA1A gene is associated with a condition called spinocerebellar ataxia type 6 (SCA6). SCA6 is an autosomal dominant genetic disorder that affects the cerebellum, which is the part of the brain responsible for coordinating movement. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SCA6, NGS genetic testing can identify mutations or variations in the CACNA1A gene that are associated with the condition. By analyzing the CACNA1A gene, NGS testing can determine if a person has a mutation or variation in the gene that is known to cause SCA6. This information can be used for diagnosis, genetic counseling, and to guide treatment options. It’s important to note that NGS genetic testing can also identify other genetic variations that may not be directly related to SCA6 but could have implications for an individual’s health. Therefore, it’s essential to consult with a healthcare professional or genetic counselor to interpret the results accurately and understand their implications. |